• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

妇科恶性肿瘤立体定向体部放射治疗的质量保证

Quality Assurance for Stereotactic Body Radiation Therapy for Gynecologic Malignancies.

作者信息

Andersen Samuel N, Bonnen Mark D, Ludwig Michelle S, Dalwadi Shraddha M

机构信息

Radiation Oncology, University of Texas Health San Antonio MD Anderson Cancer Center, San Antonio, USA.

Radiation Oncology, Baylor College of Medicine, Houston, USA.

出版信息

Cureus. 2024 Feb 2;16(2):e53470. doi: 10.7759/cureus.53470. eCollection 2024 Feb.

DOI:10.7759/cureus.53470
PMID:38435154
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10909451/
Abstract

The use of stereotactic body radiation therapy (SBRT) is not well studied or reported in the treatment of gynecologic malignancies, despite its success in the definitive management of other cancer sites. This report describes a rigorous quality assurance process for patients to undergo dose escalation to the pelvis via stereotactic photon beam irradiation. Patients who receive SBRT must be ineligible for conventional brachytherapy boost and undergo comprehensive informed consent. Fiducial placement, bowel prep, Foley catheter placement with standardized bladder filling, computerized tomography (CT) simulation with whole-body immobilization, magnetic resonance imaging (MRI)-assisted target delineation, planning aims based on the established brachytherapy literature, and physics consultation for SBRT plan optimization are necessary. Prior to each fraction, the simulation position is reproduced and verified with on-table cone beam CT, and the position is maintained with whole-body immobilization. Following treatment, the treating physician is active in survivorship and toxicity management. Gynecologic SBRT is an ongoing area of study, and preliminary successes in delivering high-quality stereotactic dose escalation suggest prospective investigation is warranted. By adhering to strict quality control measures and following a pre-defined best standard of practice, patients with gynecologic malignancies who are ineligible for traditional brachytherapy procedures can be safely treated with SBRT.

摘要

尽管立体定向体部放射治疗(SBRT)在其他癌症部位的确定性治疗中取得了成功,但在妇科恶性肿瘤治疗中的研究和报道并不充分。本报告描述了一个严格的质量保证流程,用于患者通过立体定向光子束照射对盆腔进行剂量递增治疗。接受SBRT的患者必须不符合传统近距离放疗加量的条件,并需获得全面的知情同意。放置基准标记、肠道准备、放置Foley导管并进行标准化膀胱充盈、采用全身固定的计算机断层扫描(CT)模拟、磁共振成像(MRI)辅助靶区勾画、基于既定近距离放疗文献的计划目标以及进行SBRT计划优化的物理会诊都是必要的。在每次分次治疗前,通过治疗台上的锥形束CT重现并验证模拟位置,并通过全身固定保持该位置。治疗后,主治医生积极参与生存和毒性管理。妇科SBRT是一个正在进行研究的领域,在提供高质量立体定向剂量递增方面取得的初步成功表明有必要进行前瞻性研究。通过坚持严格的质量控制措施并遵循预先定义的最佳实践标准,不符合传统近距离放疗程序的妇科恶性肿瘤患者可以安全地接受SBRT治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46c9/10909451/1c1f16f7fb98/cureus-0016-00000053470-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46c9/10909451/9a260ac2265f/cureus-0016-00000053470-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46c9/10909451/f19073025ab5/cureus-0016-00000053470-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46c9/10909451/1c1f16f7fb98/cureus-0016-00000053470-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46c9/10909451/9a260ac2265f/cureus-0016-00000053470-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46c9/10909451/f19073025ab5/cureus-0016-00000053470-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46c9/10909451/1c1f16f7fb98/cureus-0016-00000053470-i03.jpg

相似文献

1
Quality Assurance for Stereotactic Body Radiation Therapy for Gynecologic Malignancies.妇科恶性肿瘤立体定向体部放射治疗的质量保证
Cureus. 2024 Feb 2;16(2):e53470. doi: 10.7759/cureus.53470. eCollection 2024 Feb.
2
Versatility of the Novalis system to deliver image-guided stereotactic body radiation therapy (SBRT) for various anatomical sites.诺瓦利斯系统在为各种解剖部位提供图像引导立体定向体部放射治疗(SBRT)方面的多功能性。
Technol Cancer Res Treat. 2007 Aug;6(4):347-54. doi: 10.1177/153303460700600412.
3
Stereotactic Body Radiation Therapy for Gynecologic Malignancies: A Case-Based Radiosurgery Society Practice Review.立体定向体部放射治疗妇科恶性肿瘤:基于病例的放射外科协会实践综述。
Pract Radiat Oncol. 2024 May-Jun;14(3):252-266. doi: 10.1016/j.prro.2023.09.008. Epub 2023 Oct 22.
4
Dosimetric feasibility of stereotactic body radiation therapy as an alternative to brachytherapy for definitive treatment of medically inoperable early stage endometrial cancer.立体定向体部放射治疗作为不能手术的早期子宫内膜癌根治性治疗手段替代近距离放疗的剂量学可行性。
Radiat Oncol. 2014 Jul 24;9:164. doi: 10.1186/1748-717X-9-164.
5
Determining the recommended dose of stereotactic body radiotherapy boost in patients with cervical cancer who are unsuitable for intracavitary brachytherapy: a phase I dose-escalation study.确定不适合腔内近距离放疗的宫颈癌患者立体定向体部放疗推量的推荐剂量:一项 I 期剂量递增研究。
Jpn J Clin Oncol. 2019 Sep 1;49(9):856-861. doi: 10.1093/jjco/hyz074.
6
Stereotactic Body Radiation Therapy Boost for Intermediate-Risk Prostate Cancer: A Phase 1 Dose-Escalation Study.立体定向体部放射治疗中危前列腺癌的增敏作用:1 期剂量递增研究。
Int J Radiat Oncol Biol Phys. 2019 Aug 1;104(5):1066-1073. doi: 10.1016/j.ijrobp.2019.04.006. Epub 2019 Apr 16.
7
Is SBRT Boost Feasible for PET Positive Lymph Nodes for Cervical Cancer? Evaluation using Tumor Control Probability and QUANTEC Criteria.SBRT 推量是否可行用于宫颈癌阳性淋巴结?使用肿瘤控制概率和 QUANTEC 标准进行评估。
Pract Radiat Oncol. 2019 Mar;9(2):e156-e163. doi: 10.1016/j.prro.2018.10.012. Epub 2018 Nov 8.
8
Brachytherapy boost (BT-boost) or stereotactic body radiation therapy boost (SBRT-boost) for high-risk prostate cancer (HR-PCa).近距离放疗 boost(BT-boost)或立体定向体部放疗 boost(SBRT-boost)治疗高危前列腺癌(HR-PCa)。
Cancer Radiother. 2021 Jun;25(4):400-409. doi: 10.1016/j.canrad.2020.11.004. Epub 2021 Jan 18.
9
Stereotactic body radiotherapy for the treatment of oligometastatic gynecological malignancy in the abdomen and pelvis: A single-institution experience.立体定向体部放疗治疗腹部和盆腔寡转移妇科恶性肿瘤:单机构经验
J Radiosurg SBRT. 2021;7(3):189-197.
10
Brachytherapy Versus Stereotactic Body Radiotherapy for Cervical Cancer Boost: A Dosimetric Comparison.近距离放射治疗与立体定向体部放射治疗用于宫颈癌增敏:剂量学比较
Cureus. 2023 Apr 7;15(4):e37235. doi: 10.7759/cureus.37235. eCollection 2023 Apr.

本文引用的文献

1
Stereotactic Body Radiation Therapy for Gynecologic Malignancies: A Case-Based Radiosurgery Society Practice Review.立体定向体部放射治疗妇科恶性肿瘤:基于病例的放射外科协会实践综述。
Pract Radiat Oncol. 2024 May-Jun;14(3):252-266. doi: 10.1016/j.prro.2023.09.008. Epub 2023 Oct 22.
2
Non-invasive stereotactic ablative boost in patients with locally advanced cervical cancer.局部晚期宫颈癌患者的非侵入性立体定向消融助推治疗。
Int J Gynecol Cancer. 2020 Nov;30(11):1684-1688. doi: 10.1136/ijgc-2019-001104. Epub 2020 Jul 6.
3
A Phase II Trial of Stereotactic Ablative Radiation Therapy as a Boost for Locally Advanced Cervical Cancer.
立体定向消融放疗作为局部晚期宫颈癌增敏的 II 期临床试验。
Int J Radiat Oncol Biol Phys. 2020 Mar 1;106(3):464-471. doi: 10.1016/j.ijrobp.2019.10.042. Epub 2019 Nov 5.
4
Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non-Small-Cell Lung Cancer: NRG Oncology/RTOG 0813 Trial.一种用于中央型非小细胞肺癌的五分割立体定向体放射治疗方案的安全性和疗效:NRG 肿瘤学/RTOG 0813 试验。
J Clin Oncol. 2019 May 20;37(15):1316-1325. doi: 10.1200/JCO.18.00622. Epub 2019 Apr 3.
5
Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology.《宫颈癌(第 3.2019 版)》,NCCN 肿瘤学临床实践指南。
J Natl Compr Canc Netw. 2019 Jan;17(1):64-84. doi: 10.6004/jnccn.2019.0001.
6
The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies.EMBRACE II研究:GEC-ESTRO妇科工作组及EMBRACE研究二十年发展的成果与展望
Clin Transl Radiat Oncol. 2018 Jan 11;9:48-60. doi: 10.1016/j.ctro.2018.01.001. eCollection 2018 Feb.
7
Uterine Neoplasms, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology.《子宫肿瘤(第 1.2018 版)》,NCCN 肿瘤学临床实践指南。
J Natl Compr Canc Netw. 2018 Feb;16(2):170-199. doi: 10.6004/jnccn.2018.0006.
8
Stereotactic Body Radiation Therapy, Intensity-Modulated Radiation Therapy, and Brachytherapy Boost Modalities in Invasive Cervical Cancer: A Study of the National Cancer Data Base.立体定向体部放射治疗、强度调制放射治疗和近距离放射治疗在侵袭性宫颈癌中的应用:国家癌症数据库研究。
Int J Gynecol Cancer. 2018 Mar;28(3):563-574. doi: 10.1097/IGC.0000000000001200.
9
Triple-tandem high-dose-rate brachytherapy for early-stage medically inoperable endometrial cancer: Initial report on acute toxicity and dosimetric comparison to stereotactic body radiation therapy.三联高剂量率近距离放疗用于早期医学上无法手术的子宫内膜癌:急性毒性的初步报告及与立体定向体部放疗的剂量学比较
Brachytherapy. 2017 Jan-Feb;16(1):141-146. doi: 10.1016/j.brachy.2016.10.004. Epub 2016 Nov 18.
10
Stereotactic body radiotherapy for localized prostate cancer: pooled analysis from a multi-institutional consortium of prospective phase II trials.立体定向体部放疗治疗局限性前列腺癌:多机构前瞻性 II 期试验联盟的汇总分析。
Radiother Oncol. 2013 Nov;109(2):217-21. doi: 10.1016/j.radonc.2013.08.030. Epub 2013 Sep 20.